Surgery for hepatoblastoma in children with trisomy 18: a monocentric study
Pediatric Surgery International · 2024
DOI: 10.1007/s00383-024-05813-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Surgery International, 2024. Verfasst von Kazuki Hirohara und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8561, Japan. h28md.hirohara@gmail.com. Hauptthemen laut MEDLINE: Hepatoblastoma, Trisomy 18 Syndrome, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
PURPOSE: Recently, children with trisomy 18 have been receiving more active treatment for malignancies. We report herein seven cases complete resection was achieved, and discuss multidisciplinary treatment for hepatoblastoma in patients with trisomy 18. METHOD: The medical records of children with trisomy 18 who were treated at the study center between 2010 and 2023 were reviewed. RESULT: Six of 69 patients had hepatoblastoma development, and three of these underwent multidisciplinary treatment. In addition, 6 patients had been referred by another hospital for treatment, and four of these underwent multidisciplinary treatment. Among the seven patients who underwent multidisciplinary treatment, three, two, and two were categorized in Pre-treatment Extent of Disease (PRETEXT) classification group I, II, and III, respectively. Neoadjuvant chemotherapy resulting in tumor reduction was performed in three cases. In all the cases, complete resection was achieved with pathologically safe margins. Perioperative complications included circulatory failure in one case and bile leakage in two cases. Adjuvant chemotherapy was administered in four cases. The postoperative observation period ranged from 3 months to 11 years, and all the patients are recurrence-free. CONCLUSION: Children with trisomy 18 complicated with hepatoblastoma whose cardiopulmonary conditions are stable may be good candidates for chemotherapy and surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8561, Japan. h28md.hirohara@gmail.com.
- Department of Surgery, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8561, Japan.
- Division of Pediatric Surgery, Department of Pediatric Surgical Specialties, National Center for Child Health and Development, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
- Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8561, Japan.
- Department of Pathology, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8561, Japan.
Zitieren
APA
Hirohara, K., Tomita, H., Shimojima, N., Tsukizaki, A., Mori, T., Minegishi, H., Makimoto, A., Yuza, Y., Matsuoka, K., & Shimotakahara, A. (2024). Surgery for hepatoblastoma in children with trisomy 18: a monocentric study. Pediatric Surgery International. https://doi.org/10.1007/s00383-024-05813-x
Vancouver
Hirohara K, Tomita H, Shimojima N, Tsukizaki A, Mori T, Minegishi H, et al. Surgery for hepatoblastoma in children with trisomy 18: a monocentric study. Pediatric Surgery International. 2024. doi:10.1007/s00383-024-05813-x
BibTeX
@article{Hirohara2024,
author = {Hirohara, Kazuki and Tomita, Hirofumi and Shimojima, Naoki and Tsukizaki, Ayano and Mori, Teizaburo and Minegishi, Hidehiro and Makimoto, Atsushi and Yuza, Yuki and Matsuoka, Kentaro and Shimotakahara, Akihiro},
title = {Surgery for hepatoblastoma in children with trisomy 18: a monocentric study},
journal = {Pediatric Surgery International},
year = {2024},
doi = {10.1007/s00383-024-05813-x}
}
EUVIMED